| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:03 UTC |
|---|
| HMDB ID | HMDB0015631 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Alvimopan |
|---|
| Description | Alvimopan, also known as entereg, belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Alvimopan is a drug which is used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. also investigated for use in the treatment of pain (acute or chronic). Alvimopan is a very strong basic compound (based on its pKa). In humans, alvimopan is involved in alvimopan action pathway. Alvimopan is indicated in people to avoid postoperative ileus following partial large or small bowel resection with primary anastomosis. Unlike methylnaltrexone (another peripherally acting μ-receptor antagonist) that bears a quaternary amine, alvimopan owes its selectivity for peripheral receptors to its kinetics. Gut metabolism produces an active metabolite with no clinically significant contribution to drug effect. Therefore, no interactions are expected with hepatically metabolized drugs. Alvimopan is substrate for P-glycoprotein. |
|---|
| Structure | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1 InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| ADL 8-2698Entereg | HMDB | | ADL 8-2698 | HMDB | | Anhydrous alvimopan | HMDB | | trans-3,4-Dimethyl-4-(3-hydroxyphenyl) piperidine | HMDB | | Entereg | HMDB | | Alvimopan anhydrous | HMDB |
|
|---|
| Chemical Formula | C25H32N2O4 |
|---|
| Average Molecular Weight | 424.5326 |
|---|
| Monoisotopic Molecular Weight | 424.236207522 |
|---|
| IUPAC Name | 2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid |
|---|
| Traditional Name | alvimopan |
|---|
| CAS Registry Number | 156053-89-3 |
|---|
| SMILES | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1 |
|---|
| InChI Key | UPNUIXSCZBYVBB-JVFUWBCBSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Peptidomimetics |
|---|
| Sub Class | Hybrid peptides |
|---|
| Direct Parent | Hybrid peptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Hybrid peptide
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Phenylpiperidine
- Beta amino acid or derivatives
- Alpha-amino acid or derivatives
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- Monocyclic benzene moiety
- Benzenoid
- Piperidine
- Fatty acyl
- Fatty amide
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Carboxamide group
- Amino acid
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organic oxygen compound
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0083 g/L | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.02 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.4129 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.36 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 72.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1632.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 177.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 189.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 135.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 419.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 429.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 373.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 880.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 467.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1255.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 276.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 323.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 248.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 310.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Alvimopan,1TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3447.0 | Semi standard non polar | 33892256 | | Alvimopan,1TMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3494.3 | Semi standard non polar | 33892256 | | Alvimopan,1TMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3421.5 | Semi standard non polar | 33892256 | | Alvimopan,2TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3422.5 | Semi standard non polar | 33892256 | | Alvimopan,2TMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3366.7 | Semi standard non polar | 33892256 | | Alvimopan,2TMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3411.5 | Semi standard non polar | 33892256 | | Alvimopan,3TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3389.0 | Semi standard non polar | 33892256 | | Alvimopan,3TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3350.7 | Standard non polar | 33892256 | | Alvimopan,3TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3829.7 | Standard polar | 33892256 | | Alvimopan,1TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3698.6 | Semi standard non polar | 33892256 | | Alvimopan,1TBDMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3732.9 | Semi standard non polar | 33892256 | | Alvimopan,1TBDMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3706.2 | Semi standard non polar | 33892256 | | Alvimopan,2TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3852.6 | Semi standard non polar | 33892256 | | Alvimopan,2TBDMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3853.8 | Semi standard non polar | 33892256 | | Alvimopan,2TBDMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3908.4 | Semi standard non polar | 33892256 | | Alvimopan,3TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 4055.7 | Semi standard non polar | 33892256 | | Alvimopan,3TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3945.1 | Standard non polar | 33892256 | | Alvimopan,3TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 4020.4 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fr6-5947300000-a56d3fba4a79398cd53e | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (2 TMS) - 70eV, Positive | splash10-0fkc-9030260000-07291dc02727a1b76e9c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Positive-QTOF | splash10-00b9-4135900000-cdd9dcd5c0e44a4d2c3a | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Positive-QTOF | splash10-00di-7659100000-c6c4baaf84ffc4a524ff | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Positive-QTOF | splash10-01ba-4921000000-1d5e9cec550e68fc676d | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Negative-QTOF | splash10-00di-0013900000-26c80cc1229d409f18b0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Negative-QTOF | splash10-0fk9-2389700000-5887ae4c83be056c9be4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Negative-QTOF | splash10-0udi-7690000000-04222ab40d4c3cdf96dd | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Positive-QTOF | splash10-004i-0116900000-7e677f87932e437c28b8 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Positive-QTOF | splash10-056r-0179500000-9a36c62b4f259dfc6d00 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Positive-QTOF | splash10-014i-1921000000-c9da581bb4acc528324a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Negative-QTOF | splash10-00fr-0009800000-6c5de1cc3dd55967c60b | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Negative-QTOF | splash10-00fr-4509100000-844a82b338df3daf6e8e | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Negative-QTOF | splash10-01b9-7975000000-248c5b20b32a461b463d | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|